Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue.
Prostate field cancerization denotes molecular alterations in histologically normal tissues adjacent to tumors. Such alterations include deregulated protein expression, as we have previously shown for the key transcription factor early growth response 1 (EGR-1) and the lipogenic enzyme fatty acid sy...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4358924?pdf=render |
id |
doaj-700822ad8eb147b492580151c2a048af |
---|---|
record_format |
Article |
spelling |
doaj-700822ad8eb147b492580151c2a048af2020-11-25T02:32:14ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01103e011931410.1371/journal.pone.0119314Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue.Anna C JonesKresta S AntillonShannon M JenkinsSara N JanosHeidi N OvertonDor S ShoshanEdgar G FischerKristina A TrujilloMarco BisoffiProstate field cancerization denotes molecular alterations in histologically normal tissues adjacent to tumors. Such alterations include deregulated protein expression, as we have previously shown for the key transcription factor early growth response 1 (EGR-1) and the lipogenic enzyme fatty acid synthase (FAS). Here we add the two secreted factors macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) to the growing list of protein markers of prostate field cancerization. Expression of MIC-1 and PDGF-A was measured quantitatively by immunofluorescence and comprehensively analyzed using two methods of signal capture and several groupings of data generated in human cancerous (n = 25), histologically normal adjacent (n = 22), and disease-free (n = 6) prostate tissues. A total of 208 digitized images were analyzed. MIC-1 and PDGF-A expression in tumor tissues were elevated 7.1x to 23.4x and 1.7x to 3.7x compared to disease-free tissues, respectively (p<0.0001 to p = 0.08 and p<0.01 to p = 0.23, respectively). In support of field cancerization, MIC-1 and PDGF-A expression in adjacent tissues were elevated 7.4x to 38.4x and 1.4x to 2.7x, respectively (p<0.0001 to p<0.05 and p<0.05 to p = 0.51, respectively). Also, MIC-1 and PDGF-A expression were similar in tumor and adjacent tissues (0.3x to 1.0x; p<0.001 to p = 0.98 for MIC-1; 0.9x to 2.6x; p<0.01 to p = 1.00 for PDGF-A). All analyses indicated a high level of inter- and intra-tissue heterogeneity across all types of tissues (mean coefficient of variation of 86.0%). Our data shows that MIC-1 and PDGF-A expression is elevated in both prostate tumors and structurally intact adjacent tissues when compared to disease-free specimens, defining field cancerization. These secreted factors could promote tumorigenesis in histologically normal tissues and lead to tumor multifocality. Among several clinical applications, they could also be exploited as indicators of disease in false negative biopsies, identify areas of repeat biopsy, and add molecular information to surgical margins.http://europepmc.org/articles/PMC4358924?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Anna C Jones Kresta S Antillon Shannon M Jenkins Sara N Janos Heidi N Overton Dor S Shoshan Edgar G Fischer Kristina A Trujillo Marco Bisoffi |
spellingShingle |
Anna C Jones Kresta S Antillon Shannon M Jenkins Sara N Janos Heidi N Overton Dor S Shoshan Edgar G Fischer Kristina A Trujillo Marco Bisoffi Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue. PLoS ONE |
author_facet |
Anna C Jones Kresta S Antillon Shannon M Jenkins Sara N Janos Heidi N Overton Dor S Shoshan Edgar G Fischer Kristina A Trujillo Marco Bisoffi |
author_sort |
Anna C Jones |
title |
Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue. |
title_short |
Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue. |
title_full |
Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue. |
title_fullStr |
Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue. |
title_full_unstemmed |
Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue. |
title_sort |
prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (mic-1) and platelet derived growth factor a (pdgf-a) in tumor adjacent tissue. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2015-01-01 |
description |
Prostate field cancerization denotes molecular alterations in histologically normal tissues adjacent to tumors. Such alterations include deregulated protein expression, as we have previously shown for the key transcription factor early growth response 1 (EGR-1) and the lipogenic enzyme fatty acid synthase (FAS). Here we add the two secreted factors macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) to the growing list of protein markers of prostate field cancerization. Expression of MIC-1 and PDGF-A was measured quantitatively by immunofluorescence and comprehensively analyzed using two methods of signal capture and several groupings of data generated in human cancerous (n = 25), histologically normal adjacent (n = 22), and disease-free (n = 6) prostate tissues. A total of 208 digitized images were analyzed. MIC-1 and PDGF-A expression in tumor tissues were elevated 7.1x to 23.4x and 1.7x to 3.7x compared to disease-free tissues, respectively (p<0.0001 to p = 0.08 and p<0.01 to p = 0.23, respectively). In support of field cancerization, MIC-1 and PDGF-A expression in adjacent tissues were elevated 7.4x to 38.4x and 1.4x to 2.7x, respectively (p<0.0001 to p<0.05 and p<0.05 to p = 0.51, respectively). Also, MIC-1 and PDGF-A expression were similar in tumor and adjacent tissues (0.3x to 1.0x; p<0.001 to p = 0.98 for MIC-1; 0.9x to 2.6x; p<0.01 to p = 1.00 for PDGF-A). All analyses indicated a high level of inter- and intra-tissue heterogeneity across all types of tissues (mean coefficient of variation of 86.0%). Our data shows that MIC-1 and PDGF-A expression is elevated in both prostate tumors and structurally intact adjacent tissues when compared to disease-free specimens, defining field cancerization. These secreted factors could promote tumorigenesis in histologically normal tissues and lead to tumor multifocality. Among several clinical applications, they could also be exploited as indicators of disease in false negative biopsies, identify areas of repeat biopsy, and add molecular information to surgical margins. |
url |
http://europepmc.org/articles/PMC4358924?pdf=render |
work_keys_str_mv |
AT annacjones prostatefieldcancerizationderegulatedexpressionofmacrophageinhibitorycytokine1mic1andplateletderivedgrowthfactorapdgfaintumoradjacenttissue AT krestasantillon prostatefieldcancerizationderegulatedexpressionofmacrophageinhibitorycytokine1mic1andplateletderivedgrowthfactorapdgfaintumoradjacenttissue AT shannonmjenkins prostatefieldcancerizationderegulatedexpressionofmacrophageinhibitorycytokine1mic1andplateletderivedgrowthfactorapdgfaintumoradjacenttissue AT saranjanos prostatefieldcancerizationderegulatedexpressionofmacrophageinhibitorycytokine1mic1andplateletderivedgrowthfactorapdgfaintumoradjacenttissue AT heidinoverton prostatefieldcancerizationderegulatedexpressionofmacrophageinhibitorycytokine1mic1andplateletderivedgrowthfactorapdgfaintumoradjacenttissue AT dorsshoshan prostatefieldcancerizationderegulatedexpressionofmacrophageinhibitorycytokine1mic1andplateletderivedgrowthfactorapdgfaintumoradjacenttissue AT edgargfischer prostatefieldcancerizationderegulatedexpressionofmacrophageinhibitorycytokine1mic1andplateletderivedgrowthfactorapdgfaintumoradjacenttissue AT kristinaatrujillo prostatefieldcancerizationderegulatedexpressionofmacrophageinhibitorycytokine1mic1andplateletderivedgrowthfactorapdgfaintumoradjacenttissue AT marcobisoffi prostatefieldcancerizationderegulatedexpressionofmacrophageinhibitorycytokine1mic1andplateletderivedgrowthfactorapdgfaintumoradjacenttissue |
_version_ |
1724820542321590272 |